Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | CETP | P11597 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | TYR | P14679 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.39 |
| ▸ | SYNJ2 | O15056 | 1/20 | 0.39 |
| ▸ | GJB2 | P29033 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14939003 | 1.00 | L3MBTL1 (0.44) | L3MBTL1MAPTCETPMAPK1GAA | |
| SCHEMBL17651845 | 1.00 | L3MBTL1 (0.44) | L3MBTL1MAPTCETPMAPK1GAA | |
| SCHEMBL1747620 | 1.00 | L3MBTL1 (0.44) | L3MBTL1MAPTCETPMAPK1GAA | |
| SCHEMBL13157184 | 1.00 | L3MBTL1 (0.44) | L3MBTL1MAPTCETPMAPK1GAA | |
| SCHEMBL5309010 | 1.00 | L3MBTL1 (0.44) | L3MBTL1MAPTCETPMAPK1GAA | |
| SCHEMBL1746034 | 0.94 | CETP (0.46) | L3MBTL1MAPTCETPMAPK1GAA | |
| SCHEMBL13157186 | 0.94 | CETP (0.46) | L3MBTL1MAPTCETPMAPK1GAA | |
| SCHEMBL1745771 | 0.94 | CETP (0.46) | L3MBTL1MAPTCETPMAPK1GAA | |
| SCHEMBL13157187 | 0.94 | CETP (0.46) | L3MBTL1MAPTCETPMAPK1GAA | |
| SCHEMBL1746439 | 0.80 | OGA (0.37) | MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2007048974-A2 | D-GLUCOSAMINE AND N-ACETYL-D-GLUCOSAMINE HETEROOLIGOMERS, METHOD FOR PREPARING SAME AND USE THEREOF | UNIVERSITE CLAUDE BERNARD LYON I (FR) | 2007-05-03 | — | — | WO | claimed |
| WO-2020232194-A1 | METHODS FOR GLYCOSYLATION | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2020-11-19 | — | — | WO | disclosed |
| EP-2563337-B1 | CARRIER AND TARGETING SYSTEM COMPRISING A SIOSOMAL COMPOSITION FOR INTRACELLULAR DELIVERY AND TARGETING OF ACTIVE SUBSTANCE | SALAMA ZOSER B (DE) | 2017-07-26 | — | — | EP | disclosed |
| EP-2776449-A2 | PROCESS FOR THE PREPARATION OF beta-C-ARYL GLUCOSIDES | Scinopharm Taiwan Ltd. (TW) | 2014-09-17 | — | — | EP | disclosed |
| WO-2013068850-A2 | PROCESS FOR THE PREPARATION OF β-C-ARYL GLUCOSIDES | SCINOPHARM TAIWAN, LTD. (NA) | 2013-05-16 | — | — | WO | disclosed |
| EP-2384743-A1 | Siosomal formulation for intracellular delivery and targeting of therapeutic agents | Salama, Zoser B. (DE) | 2011-11-09 | — | — | EP | disclosed |
| WO-2007048974-A2 | D-GLUCOSAMINE AND N-ACETYL-D-GLUCOSAMINE HETEROOLIGOMERS, METHOD FOR PREPARING SAME AND USE THEREOF | UNIVERSITE CLAUDE BERNARD LYON I (FR) | 2007-05-03 | — | — | WO | disclosed |